Original from: Genomeweb

In addition, personnel, equipment, and facilities from the acquired companies will expand Reaction Biology’s presence in Germany while enabling its global customers to leverage Bioassay’s expansive portfolio of regulated clinical and commercial services.

Reaction Biology Corporation announced on December 2, 2022 that their closure on a definitive agreement for Reaction to acquire Bioassay Labor für biologische Analytik GmbH (Bioassay GmbH), including its wholly owned subsidiary, Peptide Specialty Laboratories GmbH (PSL), located in Heidelberg, Germany.

Bioassay offers good manufacturing practices (GMP)-accredited potency assays and functional bioassays, good laboratory practices (GLP)-compliant services, and through PSL, peptide synthesis services, including peptide-specific antibody production and neoantigen synthesis.

Source: Reaction Biology Acquires Bioassay GmbH for Increasing Large Molecule Capabilities